The company’s A shares are not listed and are held by Novo Holdings
A/S, a Danish public limited liability company wholly owned by the
Novo Nordisk Foundation.
The Foundation has a dual objective: to provide a stable basis for
the commercial and research activities conducted by the companies
within the Novo Group (of which Novo Nordisk is the largest), and to
support scientific and humanitarian purposes. According to the
Articles of Association of the Foundation, the A shares cannot be divested.
As of 11 May 2020, Novo Holdings A/S also held a B share capital of
nominally DKK 25,750,300. Novo Nordisk’s A and B shares are calculated
in units of DKK 0.20. Each A share carries 200 votes and each B share
carries 20 votes.